The Use of Metformin in Pregnant Women Without Diabetes

Sandi Harris, Mercer University College of Pharmacy

 

According to a review of eight studies, research to evaluate the effects on both mother and fetus with the use of metformin in pregnant women who have been diagnosed with diabetes has shown some benefit. [1]

 

It has been stated that there is a positive correlation between maternal pre-pregnancy weight and gestational weight gain on the birth weight of the neonate. [2]

 

Title: Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus
Design Double-blind, placebo-controlled trial; N= 400
Objective To evaluate the effect on infant birth weight of metformin in women without diabetes who have a body mass index (BMI) of at least 35
Study Groups Women receiving 3000 mg metformin daily during pregnancy (n= 202); Women receiving a placebo as a control group (n= 198)
Methods The metformin or placebo was given with meals; metformin was initiated at a daily dose of 1.0 g in week 1, and the dose was increased by 0.5 g per week to a maximum dose of 3.0 g in week 5. Women with serious side effects while taking the full dose were asked to continue taking the maximum tolerated dose.
Duration  October, 2010 – June, 2015
Primary Outcome Measure  The median neonatal birth-weight z score (difference between observed and expected birth weight, with adjustment for gestational age, divided by the fitted standard deviation).
Baseline Characteristics Metformin Group

(n= 202)

Placebo

(n= 198)

Maternal age, y 32.9 30.8
Maternal BMI 38.6 38.4
Gestational age

at enrollment

15.1 14.9
White 142 128
Black 50 55
Asian 8 12
Mixed race 2 3
Results Z-score= 0.05 in the metformin group [interquartile range, -0.71 to 0.92];  Z-score= 0.17 in the placebo group [interquartile range, -0.62 to 0.89] (p= 0.66)
Adverse Events Common Adverse Events: N/A
Serious Adverse Events: Fetal growth restriction (1%)
Percentage that Discontinued due to Adverse Events: 17.6%
Study Author Conclusions Among women without diabetes who had a BMI of more than 35, the antenatal administration of metformin reduced maternal weight gain but not neonatal birth weight

 

This study shows that the birth weight of the baby was not affected when obese women who did not have diabetes received metformin during their pregnancy.  Metformin may be an option to manage weight gain of the mother during pregnancy without negatively affecting the weight of the fetus.

 

References

  1. Zhu B, Zhang L, Fan YY, et al. Metformin versus insulin in gestational diabetes mellitus: a meta-analysis of randomized clinical trials. Ir J Med Sci. 2016.
  2. Santangeli L, Sattar N, Huda SS. Impact of maternal obesity on perinatal and childhood outcomes. Best Pract Res Clin Obstet Gynaecol. 2015;29(3):438-48.
  3. Syngelaki A, Nicolaides KH, Balani J, et al. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. N Engl J Med. 2016;374(5):434-43.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s